CGAS and plasma cell myeloma: After treatment of myeloma cells with chemotherapeutic drugs such as bortezomib or melphalan, DNA damage is induced, activating the cyclic guanosine monophosphate (GMP)‐adenosine monophosphate (AMP) synthase (cGAS)/stimulator of interferon genes (STING) signaling pathway.